Harvard – Tectonic Therapeutic, License Agreement Post author:GHIAA Admin Post published:June 30, 2025 Post category: Continue ReadingHarvard – Tectonic Therapeutic, License Agreement
Atreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement Post author:GHIAA Admin Post published:June 26, 2025 Post category: Continue ReadingAtreca – Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement
Visterra – Serum Institute of India, Dengue Fever Therapeutic, License and Collaboration Agreement Post author:GHIAA Admin Post published:May 27, 2025 Post category: Continue ReadingVisterra – Serum Institute of India, Dengue Fever Therapeutic, License and Collaboration Agreement
UCLA – Radiopharm Theranostics, Cancer Therapeutic & Diagnostic (DUNP19 antibody) License Agreement Post author:GHIAA Admin Post published:April 28, 2025 Post category: Continue ReadingUCLA – Radiopharm Theranostics, Cancer Therapeutic & Diagnostic (DUNP19 antibody) License Agreement
UK Lambert Toolkit, Model Consortium Agreement C Post author:GHIAA Admin Post published:March 17, 2025 Post category: Continue ReadingUK Lambert Toolkit, Model Consortium Agreement C
UK Lambert Toolkit, Model Consortium Agreement B Post author:GHIAA Admin Post published:March 17, 2025 Post category: Continue ReadingUK Lambert Toolkit, Model Consortium Agreement B
UK Lambert Toolkit, Model Consortium Agreement A Post author:GHIAA Admin Post published:March 13, 2025 Post category: Continue ReadingUK Lambert Toolkit, Model Consortium Agreement A
GOSH Charity Grant Terms and Conditions Post author:GHIAA Admin Post published:March 4, 2025 Post category: Continue ReadingGOSH Charity Grant Terms and Conditions
MPP – Afrigen Biologics, RSV mRNA-Based Vaccine, Grant Agreement Post author:GHIAA Admin Post published:December 3, 2024 Post category: Continue ReadingMPP – Afrigen Biologics, RSV mRNA-Based Vaccine, Grant Agreement